CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies today announced that Fierce Biotech has named it as one of 2022’s “Fierce 15” biotechnology companies, designating ...

Stealth biotech Arbor steps out of the shadows, announcing it’s found a new CRISPR enzyme. Sharon Begley. Updated Thu, March 15, 2018 at 4:00 PM UTC.

Three years ago, Arbor Biotechnologies CEO Devyn Smith appeared at the J.P. Morgan Healthcare Conference and laid out a grand vision: With $215 million in new capital, the biotech would push ...

Allogene’s AlloCAR T™ Autoimmune Disease Platform Leverages Arbor’s CRISPR Gene-Editing TechnologyFirst Allogeneic CAR T Phase 1 Clinical Trial in Autoimmune Disease Expected to Initiate in ...

Stealth biotech Arbor steps out of the shadows, announcing it’s found a new CRISPR enzyme. By Sharon Begley March 15, 2018. Reprints. Arbor. A stealth biotechnology company that has attracted ...